Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 3,401–3,425 of 27,380 studies, newest first · page 137 of 1096.

August 2025 25

  1. 2025-08-22
  2. 2025-08-21

    Plasma Markers of Astrocytic and Axonal Integrity in Idiopathic/Isolated REM Sleep Behavior Disorder (iRBD) as Predictors of Dementia with Lewy Bodies

    ✓ Peer-reviewed Biomarkers Movement disorders : official journal of the Movement Disorder Society

    Key finding: A total of 143 iRBD participants (110 male, 67.7 ± 8.0 years) were included. +4 more findings

  3. 2025-08-21

    The association of retinal vessel calibre, white matter hyperintensities and cognitive decline in community-dwelling older adults

    ✓ Peer-reviewed Vascular contributions Age and Ageing

    Key finding: This study included 3540 participants with RVC data and 489 with WMH data (median [IQR] age: 73.2 [71.4-76.3] and 72.5 [71.2-75.4] years; female: 52.9% and 47.6%) over a median follow-up of 7.4 [IQR 5.5-8.5] and 3.8 [IQR 2.9-5.3] years, respectively. +4 more findings

  4. 2025-08-21
  5. 2025-08-21

    Analysis of brain dynamics changes in patients with cerebral small vessel disease-related cognitive impairment based on electroencephalogram microstates

    ✓ Peer-reviewed Vascular contributions European journal of medical research

    Key finding: Neuropsychological assessments indicated that the CSVD group scored significantly lower than the HC group in general cognitive level, memory, visuospatial ability, executive function, and language function (p < 0.05). 2. +4 more findings

  6. 2025-08-21

    Acceptability of Euthanasia for People With Dementia: Perspectives of Clinicians From Six Countries

    ✓ Peer-reviewed End-of-life care American Journal of Geriatric Psychiatry

    Key finding: Participants included 202 physicians and three nurse specialists who assumed similar medical responsibilities. +4 more findings

  7. 2025-08-21

    Advance care planning with people living with dementia: ethical considerations of physicians in the United States and the Netherlands

    ✓ Peer-reviewed End-of-life care The Journals of Gerontology Series B

    Key finding: Interviews with 50 Dutch physicians and 47 American physicians and 3 nurse practitioners generated three themes of ethical considerations: (1) Respecting the autonomy of the person with dementia, (2) Rationality as the basis for decisions and subsequent actions, and (3) Minimizing burden and suffering. +2 more findings

  8. 2025-08-21

    Apolipoprotein E, Executive Function, and Falls across Cognitive Status: A Cross-Sectional Study

    ✓ Peer-reviewed Clinical safety Dementia and Geriatric Cognitive Disorders

    Key finding: ApoE4 did not moderate the EF and falls relationship (p ≥ 0.05). +4 more findings

  9. 2025-08-21

    2′-Fucosyllactose mitigates cognitive deficits in Alzheimer models: targeting amyloid pathology, oxidative stress, and synaptic plasticity

    ✓ Peer-reviewed Disease mechanisms Frontiers in Pharmacology

    Key finding: 2′-FL improved cognitive performance in 5xFAD mice, reduced Aβ plaque deposition and pro-inflammatory cytokine levels in vivo , and mitigated oxidative stress and synaptic dysfunction in cellular models. +3 more findings

  10. 2025-08-21

    CSF markers of neuroinflammation, synaptic dysfunction and [18F]DOPA-PET in Parkinson's disease

    ✓ Peer-reviewed Inflammation and the immune system Parkinsonism & Related Disorders

    Key finding: In PD patients, a decrease in [ 18 F]DOPA PET retention correlated with disease duration as well as CSF neurodegenerative and synaptic biomarkers but not with inflammatory biomarkers or [ 18 F]RO948 PET midbrain off-target retention. +1 more finding

  11. 2025-08-21

    Mutaciones en los genes PSEN1 y PSEN2 como marcadores moleculares en la Enfermedad de Alzheimer. Revisión Sistemática

    ✓ Peer-reviewed Risk genes beyond APOE MQRInvestigar

    Key finding: Objetivo: Analizar la evidencia disponible sobre mutaciones en los genes PSEN1 y PSEN2 como marcadores moleculares en la enfermedad de Alzheimer. +4 more findings

  12. 2025-08-21
  13. 2025-08-21

    Nutritional knowledge, sociodemographic, and lifestyle factors as determinants of diet quality – a Polish population-based study

    ✓ Peer-reviewed Prevention and risk Frontiers in Public Health

    Key finding: Nutritional knowledge supports better diet quality but may not suffice especially in older adults. +2 more findings

  14. 2025-08-20

    APOE genotypes differentially remodel the astrocytic lipid droplet-associated proteome to shape lipid droplet dynamics

    ⚠ Preprint — not yet peer-reviewed Genetics bioRxiv : the preprint server for biology

    Key finding: These findings suggest that impaired lipid droplet clearance, rather than accumulation, distinguishes APOE4-associated AD risk, and may present a new metabolic node for modulating risk.

    Scored 22 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  15. 2025-08-20

    Optimizing timing and cost-effective use of plasma biomarkers in Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Alzheimer's research & therapy

    Key finding: When benchmarked against amyloid PET, plasma biomarker-based stratification achieves an optimal balance between diagnostic accuracy and cost-effectiveness. +4 more findings

  16. 2025-08-20

    Loss of col4a1 in zebrafish recapitulates the cerebrovascular phenotypes associated with monogenic cerebral small vessel disease

    ✓ Peer-reviewed Vascular contributions Matrix Biology

    Key finding: We also identified evidence for abnormal cerebrovascular basement membranes and elevated matrix metalloproteinase 9 ( mmp9) transcription associated with loss of col4a1 . +2 more findings

  17. 2025-08-20

    Perspectives of Hospice Medical Directors on Challenges and Solutions for Improving Care for Persons Living With Dementias (PLWD) and Their Caregivers

    ✓ Peer-reviewed End-of-life care American Journal of Hospice and Palliative Medicine®

    Key finding: A larger proportion of PLWD outlive the 6-month hospice eligibility requirement compared to other terminally ill patients, which leads to high rates of hospice live discharge.

  18. 2025-08-20

    Interventions for preventing falls in older people in care facilities

    ✓ Peer-reviewed Clinical safety Cochrane Database of Systematic Reviews

    Key finding: Critical outcomes were rate of falls (number of falls per unit time) and number of fallers (risk of experiencing one or more falls). +4 more findings

  19. 2025-08-20

    Artificial Intelligence and Personhood in Dementia

    ✓ Peer-reviewed Digital health tools Dementia and Geriatric Cognitive Disorders

    Key finding: The unprecedented rise of artificial intelligence (AI) in recent times is unparalleled in history.AI 1 seemingly possesses cognitive abilities that hitherto only humans could boast of -reason, an inimitable, embodied, and finite existence. 47Nonetheless, the ubiquitous abilities of AI can help to en

  20. 2025-08-20

    Risk factors for dementia and cognitive impairment within 5 years after stroke: a prospective multicentre cohort study

    ✓ Peer-reviewed How common it is The Lancet Regional Health - Europe

    Key finding: Of 736 patients (245 [33%] female, mean age 68·0 years [SD 11·2], median admission National Institutes of Health Stroke Scale (NIHSS) 3 [IQR 1-5]), 557 (76%) were followed up until death or the end of the study, and 706 (96%) contributed to the PSD analysis. +4 more findings

  21. 2025-08-20

    Race and Ethnicity and Comorbidities Among Medicare Beneficiaries With Young-Onset Dementia

    ✓ Peer-reviewed Disparities JAMA Network Open

    Key finding: In 2022, among a total of 2 189 231 Medicare beneficiaries aged 45 to 64 years, 71 092 (3.25%) received a diagnosis of YOD. +4 more findings

  22. 2025-08-20

    Improving Community-Based Palliative Care Explanations: Insights From Persons Declining Services

    ✓ Peer-reviewed Health systems and care delivery American Journal of Hospice and Palliative Medicine®

    Key finding: Community-based palliative care can help seriously ill individuals manage their conditions and improve their quality of life. +4 more findings

  23. 2025-08-19

    A nomogram for predicting post-stroke cognitive impairment no dementia in patients with first-ever mild ischemic stroke

    ✓ Peer-reviewed Vascular contributions Frontiers in Neurology

    Key finding: This validated nomogram incorporating clinical, biochemical, and neuroimaging biomarkers provides a robust tool for individualized PSCIND risk assessment in first-ever MIS patients, with potential to guide targeted interventions and cognitive monitoring. +1 more finding

  24. 2025-08-19
  25. 2025-08-19

    Exploring the effect of pre-clinical Alzheimer’s disease on blood pressure using Mendelian randomisation and parental dementia as an instrumental variable in UK Biobank

    ✓ Peer-reviewed Long-term cohort studies BMC Medicine

    Key finding: Both the higher parental dementia instrument and participant genetic instrument score were associated with higher mean SBP (difference in mean SBP mmHg per 1SD higher score: 0.12, 95% CI 0.06 to 0.17, p < 0.0001, and 0.07, 95% CI 0.00 to 0.13, p=0.037, respectively) but not DBP. +4 more findings

Browse the library by subject, with the full score breakdown →